FAM111B Suppression Enhances Sensitivity to Gemcitabine in Pancreatic Cancer Through Intracellular pH Regulation.

Nishimura M, Sunagawa M, Kokuryo T, Yamaguchi J, Baba T, Mizuno T, Onoe S, Watanabe N, Kawakatsu S, Ebata T

Open source

DOI
10.1111/cas.70212
Published
2025 Dec
Container
Cancer science
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cas.70212,
  title = {FAM111B Suppression Enhances Sensitivity to Gemcitabine in Pancreatic Cancer Through Intracellular pH Regulation.},
  author = {Nishimura M and Sunagawa M and Kokuryo T and Yamaguchi J and Baba T and Mizuno T and Onoe S and Watanabe N and Kawakatsu S and Ebata T},
  year = {2025},
  journal = {Cancer science},
  doi = {10.1111/cas.70212},
  url = {https://doi.org/10.1111/cas.70212}
}

RIS

TY  - JOUR
TI  - FAM111B Suppression Enhances Sensitivity to Gemcitabine in Pancreatic Cancer Through Intracellular pH Regulation.
AU  - Nishimura M
AU  - Sunagawa M
AU  - Kokuryo T
AU  - Yamaguchi J
AU  - Baba T
AU  - Mizuno T
AU  - Onoe S
AU  - Watanabe N
AU  - Kawakatsu S
AU  - Ebata T
PY  - 2025
JO  - Cancer science
DO  - 10.1111/cas.70212
UR  - https://doi.org/10.1111/cas.70212
ER  - 

APA

M, N., M, S., T, K., J, Y., T, B., T, M., S, O., N, W., S, K., & T, E. (2025). FAM111B Suppression Enhances Sensitivity to Gemcitabine in Pancreatic Cancer Through Intracellular pH Regulation.. Cancer science. https://doi.org/10.1111/cas.70212

Source records